ATCC announces award from national institute of allergy and infectious diseases to support its preclinical services for biopharmaceutical product development Post author: Post published:November 13, 2023 Post category:uncategorized ATCC today announced that it has been awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) contract. You Might Also Like UK’s drug payment disclosure system fails to protect patients and public trust January 9, 2025 Fast food’s grip on American diets weakens as younger adults cut back September 11, 2025 Removing a splinter? Treating a wart? If a doctor does it, it can be billed as surgery December 13, 2024
Removing a splinter? Treating a wart? If a doctor does it, it can be billed as surgery December 13, 2024